Bayer Schering Pharma Builds on Core Schering Technology in Neurodegenerative Diseases
By Business Review Editor
Pharma Deals Review: Vol 2007 Issue 80 (Table of Contents)
Published: 7 Feb-2007
DOI: 10.3833/pdr.v2007.i80.392 ISSN: 1756-7874
Section: Licensing
Fulltext:
Abstract
Bayer Schering Pharma signed a license and option agreement with Taisho Pharmaceutical, Nihon Nohyaku and the National Institute of Radiological Sciences of Japan to develop novel imaging compounds for the detection of neurodegenerative diseases...
This page is available to subscribers only.
Not a subscriber? Join here
Already Registered? Please login using the top left purple box.
Copyright: © IQVIA 2018
RSS